...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ... listened to webcast a couple times...

kelsee - He actually used the word deal at one point. Your right about his excitement. Much more enthusiastic presentation than last year.

tada

Share
New Message
Please login to post a reply